563 Results

People

  1. Zelenetz
    Zelenetz
  2. Moskowitz
    Moskowitz
  3. Yahalom
    Yahalom
  4. Noy
    Noy
  5. De Angelis
    De Angelis
  6. Perales
    Perales
  7. Abrey
    Abrey
  8. Palomba
    Palomba
  9. Younes
    Younes
  10. Matasar
    Matasar

Groups

  1. Department of Medicine (377)
  2. Hematologic Malignancies, Division of (338)
  3. Center for Hematologic Malignancies (292)
  4. Lymphoma (192)
  5. Survivorship Research (98)
  6. Tow Center for Developmental Oncology (TCDO) (72)
  7. Bone Marrow Transplant (65)
  8. GSK Faculty (60)
  9. Epidemiology and Biostatistics (58)
  10. Adult Leukemia (53)
  1. "rituximab"
Formats
  1. Journal Article (489)
  2. Review (36)
  3. Research Letter (13)
  4. Editorial (9)
  5. Correspondence (6)
  6. Meeting Abstract (4)
  7. Book Section (2)
  8. Conference Paper (2)
  9. Guidelines (2)
Groups
  1. Department of Medicine (377)
  2. Hematologic Malignancies, Division of (338)
  3. Center for Hematologic Malignancies (292)
  4. Lymphoma (192)
  5. Survivorship Research (98)
  6. Tow Center for Developmental Oncology (TCDO) (72)

More Groups

People
  1. Andrew Zelenetz (87)
  2. Craig Moskowitz (52)
  3. Joachim Yahalom (39)
  4. Ariela Noy (35)
  5. Lisa De Angelis (32)
  6. Paul Hamlin (32)

More People

Years
  1. 2025 (21)
  2. 2024 (36)
  3. 2023 (36)
  4. 2022 (28)
  5. 2021 (14)
  6. 2020 (25)

More Years

Publications
  1. Blood (43)
  2. Leukemia and Lymphoma (38)
  3. Journal of Clinical Oncology (32)
  4. Haematologica (21)
  5. British Journal of Haematology (20)
  6. Journal of the National Comprehensive Cancer Network (16)

More Publications

Publishers
  1. Elsevier Inc. (70)
  2. American Society of Hematology (61)
  3. Taylor & Francis Group (44)
  4. Springer (42)
  5. American Society of Clinical Oncology (36)
  6. Nature Publishing Group (28)

More Publishers

Results (563)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Primary leptomeningeal lymphoma: International Primary CNS lymphoma collaborative group report
    Journal Article

    Taylor, J. W.; Flanagan, E. P.; O'Neill, B. P.; Siegal, T.; Omuro, A.; DeAngelis, L.; Baehring, J.; Nishikawa, R.; Pinto, F.; Chamberlain, M.; more...
    Neurology (2013)

    Fulltext@MSK | Save
  • In the spotlight: A novel CD37 antibody-drug conjugate
    Journal Article

    Lia Palomba, M.; Younes, A.
    Blood (2013)

    Fulltext@MSK | Save
  • Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: A pooled analysis of 1546 patients
    Journal Article

    Barta, S. K.; Xue, X.; Wang, D.; Tamari, R.; Lee, J. Y.; Mounier, N.; Kaplan, L. D.; Ribera, J. M.; Spina, M.; Tirelli, U.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial
    Journal Article

    Vose, J. M.; Carter, S.; Burns, L. J.; Ayala, E.; Press, O. W.; Moskowitz, C. H.; Stadtmauer, E. A.; Mineshi, S.; Ambinder, R.; Fenske, T.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
    Journal Article

    Hu, S.; Xu-Monette, Z. Y.; Balasubramanyam, A.; Manyam, G. C.; Visco, C.; Tzankov, A.; Liu, W. M.; Miranda, R. N.; Zhang, L.; Montes-Moreno, S.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: A comprehensive analysis from the NCCN lymphoma outcomes project
    Journal Article

    Evens, A. M.; Vanderplas, A.; LaCasce, A. S.; Crosby, A. L.; Nademanee, A. P.; Kaminski, M. S.; Abel, G. A.; Millenson, M.; Czuczman, M. S.; Rodriguez, M. A.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Posttransplant lymphoproliferative disorder complicating hematopoietic stem cell transplantation in a patient with dyskeratosis congenita
    Journal Article

    Bohn, O. L.; Whitten, J.; Spitzer, B.; Kobos, R.; Prockop, S.; Boulad, F.; Arcila, M.; Wang, L.; Teruya-Feldstein, J.
    International Journal of Surgical Pathology (2013)

    Fulltext@MSK | Save
  • Primary cutaneous B-cell lymphomas: Part II. Therapy and future directions
    Journal Article

    Suarez, A. L.; Querfeld, C.; Horwitz, S.; Pulitzer, M.; Moskowitz, A.; Myskowski, P. L.
    Journal of the American Academy of Dermatology (2013)

    Fulltext@MSK | Save
  • Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?
    Journal Article

    Buchegger, F.; Mach, J. P.; Press, O. W.; Bischof Delaloye, A.; Larson, S. M.; Prior, J. O.; Ketterer, N.
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
    Journal Article

    Bashir, Q.; Khan, H.; Thall, P. F.; Liu, P.; Shah, N.; Kebriaei, P.; Parmar, S.; Oran, B.; Ciurea, S.; Nieto, Y.; more...
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save